Defining targets and establishing methods for prevention, diagnosis and therapy of inflammation, atherosclerosis and thrombosis

确定炎症、动脉粥样硬化和血栓形成的预防、诊断和治疗的目标并建立方法

基本信息

  • 批准号:
    nhmrc : GNT1079492
  • 负责人:
  • 金额:
    $ 81.5万
  • 依托单位:
  • 依托单位国家:
    澳大利亚
  • 项目类别:
    Research Fellowships
  • 财政年份:
    2015
  • 资助国家:
    澳大利亚
  • 起止时间:
    2015-01-01 至 无数据
  • 项目状态:
    已结题

项目摘要

My research focuses on preventing and treating atherosclerotic disease and its complications such as heart attack and stroke. This will be achieved by developing new imaging technologies, with the aim to detect unstable atherosclerotic plaques, as well as innovative new drugs preventing inflammation and thrombosis as the major contributors of heart attack and stroke.
我的研究重点是预防和治疗动脉粥样硬化疾病及其并发症,如心脏病发作和中风。这将通过开发新的成像技术来实现,目的是检测不稳定的动脉粥样硬化斑块,以及创新的新药来预防炎症和血栓形成,这是心脏病发作和中风的主要原因。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Prof Karlheinz Peter其他文献

Prof Karlheinz Peter的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Prof Karlheinz Peter', 18)}}的其他基金

Targeting Activated Platelets: A novel innovative approach for the sensitive detection and therapeutic targeting of various cancers and their metastases
靶向活化血小板:一种新颖的创新方法,用于各种癌症及其转移的灵敏检测和治疗靶向
  • 批准号:
    nhmrc : GNT1124670
  • 财政年份:
    2017
  • 资助金额:
    $ 81.5万
  • 项目类别:
    Project Grants
Targeting Activated Platelets: A novel innovative approach for the sensitive detection and therapeutic targeting of various cancers and their metastases
靶向活化血小板:一种新颖的创新方法,用于各种癌症及其转移的灵敏检测和治疗靶向
  • 批准号:
    nhmrc : 1124670
  • 财政年份:
    2017
  • 资助金额:
    $ 81.5万
  • 项目类别:
    Project Grants
Activated platelets as unique targets for early imaging and site-directed therapy of cardiovascular and inflammatory diseases
活化血小板作为心血管和炎症疾病早期成像和定点治疗的独特靶点
  • 批准号:
    nhmrc : 1108670
  • 财政年份:
    2016
  • 资助金额:
    $ 81.5万
  • 项目类别:
    Project Grants
Activated platelets as unique targets for early imaging and site-directed therapy of cardiovascular and inflammatory diseases
活化血小板作为心血管和炎症疾病早期成像和定点治疗的独特靶点
  • 批准号:
    nhmrc : GNT1108670
  • 财政年份:
    2016
  • 资助金额:
    $ 81.5万
  • 项目类别:
    Project Grants
Defining targets and establishing methods for prevention, diagnosis and therapy of inflammation, atherosclerosis and thrombosis
确定炎症、动脉粥样硬化和血栓形成的预防、诊断和治疗的目标并建立方法
  • 批准号:
    nhmrc : 1079492
  • 财政年份:
    2015
  • 资助金额:
    $ 81.5万
  • 项目类别:
    Research Fellowships
Systems biology to identify molecular targets for vascular disease treatment (SysVasc), with a focus on atherosclerotic plaque instability
系统生物学确定血管疾病治疗的分子靶标 (SysVasc),重点关注动脉粥样硬化斑块不稳定性
  • 批准号:
    nhmrc : 1102158
  • 财政年份:
    2015
  • 资助金额:
    $ 81.5万
  • 项目类别:
    Targeted Calls
Systems biology to identify molecular targets for vascular disease treatment (SysVasc), with a focus on atherosclerotic plaque instability
系统生物学确定血管疾病治疗的分子靶标 (SysVasc),重点关注动脉粥样硬化斑块不稳定性
  • 批准号:
    nhmrc : GNT1102158
  • 财政年份:
    2015
  • 资助金额:
    $ 81.5万
  • 项目类别:
    International Collaborations
Nanoparticle and virus assisted targeting of microRNA and DNA for the treatment of atherosclerosis, myocardial infarction and other inflammatory diseases
纳米颗粒和病毒辅助靶向microRNA和DNA治疗动脉粥样硬化、心肌梗死等炎症性疾病
  • 批准号:
    nhmrc : 1069492
  • 财政年份:
    2014
  • 资助金额:
    $ 81.5万
  • 项目类别:
    Project Grants
Defining "therapeutic" cells as well as establishing cell targeting and tracking technology for the treatment of myocardial infarction and atherosclerosis.
定义“治疗”细胞并建立细胞靶向和追踪技术来治疗心肌梗塞和动脉粥样硬化。
  • 批准号:
    nhmrc : 1070860
  • 财政年份:
    2014
  • 资助金额:
    $ 81.5万
  • 项目类别:
    Project Grants
The role of C-reactive protein (CRP) in localising inflammation to misfolded proteins and “stressed” cells: A basis for the development of new anti-inflammatory reagents?
C 反应蛋白 (CRP) 在将炎症定位于错误折叠蛋白和“应激”细胞中的作用:开发新抗炎试剂的基础?
  • 批准号:
    nhmrc : 1067214
  • 财政年份:
    2014
  • 资助金额:
    $ 81.5万
  • 项目类别:
    Project Grants

相似国自然基金

miR-29a "targets" PPAR δ对心力衰竭的作用及作为潜在标志物的研究
  • 批准号:
    81371895
  • 批准年份:
    2013
  • 资助金额:
    70.0 万元
  • 项目类别:
    面上项目

相似海外基金

HMA domain proteins as conserved targets of pathogens that exploit plasmodesmata
HMA 结构域蛋白作为利用胞间连丝的病原体的保守靶标
  • 批准号:
    BB/X016056/1
  • 财政年份:
    2024
  • 资助金额:
    $ 81.5万
  • 项目类别:
    Research Grant
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 81.5万
  • 项目类别:
    Collaborative R&D
Developmental mechanisms specifying vagal innervation of organ targets
指定器官目标迷走神经支配的发育机制
  • 批准号:
    10752553
  • 财政年份:
    2024
  • 资助金额:
    $ 81.5万
  • 项目类别:
Finding the targets of natural products in complex botanical extracts.
寻找复杂植物提取物中天然产物的靶标。
  • 批准号:
    LP230100225
  • 财政年份:
    2024
  • 资助金额:
    $ 81.5万
  • 项目类别:
    Linkage Projects
Four-stranded fungal fatality: Unveiling G-quadruplexes as future antifungal targets
四链真菌死亡:揭示 G-四链体作为未来抗真菌靶点
  • 批准号:
    BB/Y005058/1
  • 财政年份:
    2024
  • 资助金额:
    $ 81.5万
  • 项目类别:
    Research Grant
Preclinical validation of synthetic biomolecules to treat Breast Cancer from AI-enabled discovery of novel lncRNA therapeutic targets.
通过人工智能发现新型 lncRNA 治疗靶点,对合成生物分子治疗乳腺癌进行临床前验证。
  • 批准号:
    10110204
  • 财政年份:
    2024
  • 资助金额:
    $ 81.5万
  • 项目类别:
    Launchpad
Using patient-led genetics to identify new therapeutic targets in metastatic cholangiocarcinoma
利用患者主导的遗传学来确定转移性胆管癌的新治疗靶点
  • 批准号:
    EP/Y028546/1
  • 财政年份:
    2024
  • 资助金额:
    $ 81.5万
  • 项目类别:
    Fellowship
Breaking the Barrier: Mapping protein interactions in the bacterial outer membrane as targets for new antimicrobials
打破障碍:绘制细菌外膜中的蛋白质相互作用作为新抗菌药物的目标
  • 批准号:
    MR/Y012453/1
  • 财政年份:
    2024
  • 资助金额:
    $ 81.5万
  • 项目类别:
    Research Grant
Identifying novel & repurposing drug targets for Atrial Fibrillation MEDicines
识别小说
  • 批准号:
    EP/Z000211/1
  • 财政年份:
    2024
  • 资助金额:
    $ 81.5万
  • 项目类别:
    Research Grant
Develop the novel targets and immunotherapy-combination agents through targeting nuclear transport receptor
以核转运受体为靶点开发新靶点和免疫治疗联合药物
  • 批准号:
    24K13116
  • 财政年份:
    2024
  • 资助金额:
    $ 81.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了